A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
Titel:
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
Auteur:
Bossi, P. Miceli, R. Locati, L.D. Ferrari, D. Vecchio, S. Moretti, G. Denaro, N. Caponigro, F. Airoldi, M. Moro, C. Vaccher, E. Sponghini, A. Caldara, A. Rinaldi, G. Ferrau, F. Nolè, F. Lo Vullo, S. Tettamanzi, F. Hollander, L. Licitra, L.